SAC3D1 and hepatocellular carcinoma: To investigate how SAC3D1 affects the progression of hepatocellular carcinoma (HCC), we conducted enrichment analysis of BIOCARTA, Hallmark, REACTOME, PID, and KEGG pathways in samples with high SAC3D1 expression using the GSEA database (Figures 8A–E).